Tasly Pharmaceutical Group Co Ltd Sustainability Reports
The company manufactures and markets modern traditional Chinese medicines, chemical drugs, and biological products. Its products primarily target cardiovascular, cerebrovascular, and metabolic diseases.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
LEI: 300300JB9F71F58FIC88
FIGI: BBG001SK5B66
1 reports from 2024 to 2024